In this episode of Future Feed Talks, All About Feed speaks to Dr Dian Schatzmayr, R&D Program Director at DSM-Firmenich. — In this episode of Future Feed Talks, All About Feed speaks to Dr Dian Schatzmayr, R&D Program Director at dsm-firmenich.

VIDEO: Enzymes, innovation, and regulation – the future of mycotoxin risk management

28-08-2025 | Partner | Mycotoxins

Mycotoxins remain one of the most persistent challenges in animal nutrition. How can livestock producers protect animal health and performance against the constant threat of mycotoxins? In this episode of Future Feed Talks, Dr Dian Schatzmayr, R&D Program Director at dsm-firmenich, explains why effective control requires more than binders alone.

From groundbreaking enzymatic detoxification tools like FUMzyme and BBSH 797 to decades of work shaping EU and FDA regulations, Schatzmayr shares insights into the science, strategy, and future direction of mycotoxin risk management.

This Future Feed Talks episode is a collaboration between dsm-firmenich and Misset International Media.

Join 26,000+ subscribers

Subscribe to our newsletter to stay updated about all the need-to-know content in the feed sector, three times a week.

"*" indicates required fields

More about

dsm-firmenich Partner profile

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. More about dsm-firmenich